A detailed history of Invenio Wealth Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Invenio Wealth Partners LLC holds 3,864 shares of ABT stock, worth $439,104. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,864
Previous 3,953 2.25%
Holding current value
$439,104
Previous $449 Million 10.64%
% of portfolio
0.2%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $8,964 - $10,007
-89 Reduced 2.25%
3,864 $402 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $32,308 - $35,683
-295 Reduced 6.94%
3,953 $449 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $33,911 - $41,510
-376 Reduced 8.13%
4,248 $468 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $668 - $802
-7 Reduced 0.15%
4,624 $448 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $466,712 - $520,014
4,631 New
4,631 $505 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Invenio Wealth Partners LLC Portfolio

Follow Invenio Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenio Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invenio Wealth Partners LLC with notifications on news.